Printer Friendly

Agios Pharmaceuticals names new Director.

M2 EQUITYBITES-December 15, 2017-Agios Pharmaceuticals names new Director

(C)2017 M2 COMMUNICATIONS http://www.m2.com

It was reported yesterday that Agios Pharmaceuticals, a company focused on cancer and rare genetic diseases, has named Jackie Fouse as Director as the company plans to launch its first precision medicine.

Fouse joined Celgene in 2010 as chief financial officer, and most recently served as president and chief operating officer until earlier this year. Previously she worked for Alcon Laboratories, an ophthalmic pharmaceutical and medical device company.

David Schenkein, chief executive officer at Agios, said, 'Through her tenure at Celgene we had the privilege of working with Jackie and seeing first-hand the value she brings to a growing biotechnology company, so we are thrilled to welcome her to the Agios board of directors.'

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Dec 15, 2017
Words:141
Previous Article:USFDA approves Pfizer's IXIFI.
Next Article:Millennium Health names new interim CEO.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters